Karl Munger PhD, BSc

Karl Munger earned his Ph.D. degree in Biochemistry from the University of Zurich, Switzerland, followed by a postdoctoral fellowship at the National Cancer Institute in Bethesda, MD. He was a faculty member at Harvard Medical School in Boston, MA, from 1993-2014 and held a tenured position as Professor of Medicine. He moved to Tufts University School of Medicine in Boston, MA, in August 2014, where he is a Professor in the the Department of Developmental, Molecular and Chemical Biology.

The research efforts of his laboratory are focused on delineating the molecular mechanisms of human papillomavirus (HPV)-associated cancer development. He has published more than 185 articles. He serves on the Editorial Boards of Molecular Cancer, International Journal of Cancer, Genes and Cancer, Virology and Journal of Virology and is an Associate Editor for Cancer Biology and Therapy and a Section Editor for PLOS Pathogens.

Dr. Munger has been regularly participating on grant review panels for NIH, ACS and other agencies since 1995. He has served as the basic science section chair of an advisory panel for the World Health Organization (WHO) and on a committee of the National Toxicology Program, which officially designated HPVs as carcinogenic agents in humans. His current research is supported by grants from the National Institutes of Health.